|
B3GALNT2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.30899996082002E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.18569999996154E-06 |
| Normal-vs-Stage2 |
3.782800E-04 |
| Normal-vs-Stage3 |
9.68370050813405E-10 |
| Normal-vs-Stage4 |
4.30859999900335E-08 |
| Stage1-vs-Stage2 |
9.644000E-01 |
| Stage1-vs-Stage3 |
5.897700E-02 |
| Stage1-vs-Stage4 |
3.143700E-02 |
| Stage2-vs-Stage3 |
2.072400E-01 |
| Stage2-vs-Stage4 |
1.500960E-01 |
| Stage3-vs-Stage4 |
5.896400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.28109983627201E-10 |
| Normal-vs-AfricanAmerican |
3.741700E-03 |
| Normal-vs-Asian |
4.265800E-01 |
| Caucasian-vs-AfricanAmerican |
2.559200E-01 |
| Caucasian-vs-Asian |
2.742600E-03 |
| AfricanAmerican-vs-Asian |
6.936300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.96839999855314E-08 |
| Normal-vs-Female |
1.24509999976929E-07 |
| Male-vs-Female |
7.296000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.895400E-03 |
| Normal-vs-Age(41-60Yrs) |
6.83839999959801E-07 |
| Normal-vs-Age(61-80Yrs) |
3.11820003151553E-09 |
| Normal-vs-Age(81-100Yrs) |
1.009590E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.563600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.372200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.793600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.279400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.073000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.409200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.422800E-01 |
| Normal-vs-Grade 2 |
1.61669999998448E-06 |
| Normal-vs-Grade 3 |
2.01409999789348E-10 |
| Normal-vs-Grade 4 |
1.22759999998667E-06 |
| Grade 1-vs-Grade 2 |
1.755360E-01 |
| Grade 1-vs-Grade 3 |
3.194400E-02 |
| Grade 1-vs-Grade 4 |
8.766400E-02 |
| Grade 2-vs-Grade 3 |
8.034300E-02 |
| Grade 2-vs-Grade 4 |
2.557400E-01 |
| Grade 3-vs-Grade 4 |
9.562000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.19269993460148E-10 |
| Normal-vs-ccB subtype |
6.07179999999596E-05 |
| ccA subtype-vs-ccB subtype |
8.325700E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.71609999730794E-08 |
| Normal-vs-N1 |
5.355000E-03 |
| N0-vs-N1 |
9.864600E-01 |
|
|
